title: Intravenous immunoglobulin therapy: confounding effects on serological screening for toxoplasmosis during pregnancy.
abstract: The serological diagnosis of toxoplasmic infection during pregnancy is intended to prevent congenital infection of the fetus. However, in the context of recurrent pregnancy loss intravenous immunoglobulin therapy can create a biological trap for the interpretation of serological results, with potentially serious consequences for the outcome of the pregnancy.
authors.affiliation: Service de Parasitologie-Mycologie, CHU A Michallon, 38043 Grenoble Cedex, France. Herve.Pelloux@ufj-grenoble.fr
authors.forename: H
authors.initials: H
authors.lastname: Pelloux
authors.forename: H
authors.initials: H
authors.lastname: Fricker-Hidalgo
authors.forename: G
authors.initials: G
authors.lastname: Brochier
authors.forename: A
authors.initials: A
authors.lastname: Goullier-Fleuret
authors.forename: P
authors.initials: P
authors.lastname: Ambroise-Thomas
mesh_terms: D003951:Diagnostic Errors; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000175:diagnosis*; D012698:Serologic Tests; D014123:Toxoplasmosis / Q000175:diagnosis*
chemical_list: D016756:Immunoglobulins, Intravenous